Prospects of Antiangiogenic Therapy for Portal Hypertension in Liver Cirrhosis by D. V. Garbuzenko

Subjects: “…liver cirrhosis…”
Get full text

Correlation study on gut microbiota and myosteatosis in patients with liver cirrhosis by Ninghui Zhao, Jinjia Bai, Xinmiao Li, Guofen Xu, Xiujuan Fu, Jing Li, Lingyun Niu, Jia Yao, Xiaoshuang Zhou

Subjects: “…liver cirrhosis…”
Get full text

Generalized tuberculosis with long-term course in the guise of liver cirrhosis by Z. A. Lemeshko, M. V. Mayevskaya, I. N. Tikhonov, N. P. Musina, M. S. Zharkova, Ye. V. Fominykh, V. T. Ivashkin

Subjects: Get full text

Hepatocyte Turnover in Chronic HCV-Induced Liver Injury and Cirrhosis by Nikolaos P. Karidis, Ioanna Delladetsima, Stamatios Theocharis

“…Despite common pathogenetic pathways present in all forms of liver cirrhosis irrespective of etiology, hepatocyte turnover and related molecular events in HCV-induced cirrhosis are increasingly being distinguished from even “similar” causes, such as hepatitis B virus- (HBV-) related cirrhosis. …”
Get full text

Hyperammonemia: A Report of Maternal Biliary Cirrhosis and Neonatal Outcome by Deana J. Hussamy, David B. Nelson, Stephan A. Shivvers

“…Although uncommon during pregnancy, cirrhosis results in multiple medical complications impacting both mother and fetus. …”
Get full text

DIABETES MELLITUS IN PATIENTS WITH LIVER CIRRHOSIS: NEW TREATMENT OPTIONS by L. Yu. Morgunov

Subjects: Get full text

Primary Biliary Cirrhosis and Type II Autoimmune Polyglandular Syndrome by Mark Ram Borgaonkar, David Geoffrey Morgan

“…A liver biopsy confirmed the diagnosis of primary biliary cirrhosis (PBC). She underwent a liver transplantation in January 1998. …”
Get full text

Lifetime of patients and prognostic value of manifestations and complications of liver cirrhosis by G. K. Mirodzhov, S. A. Avezov, N. S. Tukhtayeva, A. Bakhtibekov, M. M. Giyasov

Subjects: “…liver cirrhosis…”
Get full text

Serum Endocan as a Survival Predictor for Patients with Liver Cirrhosis by Nobuyuki Toshikuni, Kazuaki Ozaki, Joseph George, Mikihiro Tsutsumi

Get full text

QuickStroop for screening for minimal hepatic encephalopathy in patients with cirrhosis by Christian Labenz, Simon J. Gairing, Leonard Kaps, Alena F. Ehrenbauer, Eva M. Schleicher, Sophie Mengel, Julius F.M. Egge, Maria M. Gabriel, Peter R. Galle, Heiner Wedemeyer, Alexander Zipprich, Cristina Ripoll, Robin Greinert, Benjamin Maasoumy

“…Another independent cohort comprising 104 patients with cirrhosis from a different center served as a validation set. …”
Get full text

An Asymptomatic Male with Coexisting Celiac Disease and Primary Biliary Cirrhosis by Franzjosef Schweiger, Jasim Radhi

“…Both primary biliary cirrhosis and celiac disease may be asymptomatic in many patients for extended periods of time. …”
Get full text

Pathological Features of New Animal Models for Primary Biliary Cirrhosis by Koichi Tsuneyama, Yuki Moritoki, Kentaro Kikuchi, Yasuni Nakanuma

“…Primary biliary cirrhosis (PBC) is an autoimmune liver disease characterized by immune mediated biliary damage and frequent appearance of autoantibodies against mitochondrial enzymes. …”
Get full text

Pasteurella multocida Septicemia in a Patient with Cirrhosis: An Autopsy Report by Takuma Yamamoto, Takahiro Umehara, Takehiko Murase, Kazuya Ikematsu

“…We report an autopsy case of a 57-year-old man affected by cirrhosis. Septic shock with Pasteurella multocida pneumonia was the cause of his death. …”
Get full text

Effects of Thalidomide on the Expression of Adhesion Molecules in Rat Liver Cirrhosis

“…<p>This study was to evaluate the effects of thalidomide on expression of adhesion molecules in liver cirrhosis. The cirrhosis was induced in Wistar rats by intraperitoneal injection of <mml:math> <mml:mrow> <mml:msub> <mml:mrow> <mml:mtext>CCl</mml:mtext> </mml:mrow> <mml:mn>4</mml:mn> </mml:msub> </mml:mrow> </mml:math>, and thalidomide (10 mg/kg/day or 100 mg/kg/day) was given by intragastric administration for 8 weeks. …”
Get full text

Investigation of hemostasis by thromboelastography in the patient with liver cirrhosis (Clinical case) by Ye. L. Bulanova, A. Yu. Bulanov, D. S. Gatsolayeva

Subjects: “…liver cirrhosis…”
Get full text

Effects of Thalidomide on the Expression of Adhesion Molecules in Rat Liver Cirrhosis by Peng Lv, Shelley Chireyath Paul, Yanjv Xiao, Shiquan Liu, Hesheng Luo

“…This study was to evaluate the effects of thalidomide on expression of adhesion molecules in liver cirrhosis. The cirrhosis was induced in Wistar rats by intraperitoneal injection of CCl4, and thalidomide (10 mg/kg/day or 100 mg/kg/day) was given by intragastric administration for 8 weeks. …”
Get full text

Cryptococcus: A Rare Cause of Parotid Abscess in Liver Cirrhosis by Takeshi Okamoto, Katsuyuki Fukuda

“…A 61-year-old man with decompensated liver cirrhosis presented with a parotid mass. Fine-needle aspiration of the parotid gland revealed Cryptococcus neoformans. …”
Get full text

Liver lobes and cirrhosis: Diagnostic insights from lobar ratios by Kriti Pandey, Debabrata Dash, Raj Kumar Koiri

Subjects: “…Liver cirrhosis…”
Get full text

Update on Peripheral Arterial Vasodilation, Ascites and Hepatorenal Syndrome in Cirrhosis by Mladen Knotek, Boris Rogachev, Robert W Schrier

“…Evidence has accumulated for a major role of increased vascular production of nitric oxide as the primary cause of arterial vasodilation in cirrhosis. Ascites is a common complication in cirrhosis. …”
Get full text

Safety and Efficacy of Anticoagulation in Patients with Cirrhosis: A Meta-Analysis by Huan Chen, Jiaming Lei, Sicheng Liang, Gang Luo, Mingming Deng, Muhan Lü

“…Portal vein thrombosis is a serious adverse event that occurs during liver cirrhosis. We performed a meta-analysis to evaluate the safety and efficacy of anticoagulant therapy and prophylactic anticoagulant therapy in cirrhosis patients with (/without) portal vein thrombosis. …”
Get full text